Intrepid Financial Planning Group LLC Actinium Pharmaceuticals, Inc. Transaction History
Intrepid Financial Planning Group LLC
- $232 Million
- Q3 2024
A detailed history of Intrepid Financial Planning Group LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Intrepid Financial Planning Group LLC holds 19,000 shares of ATNM stock, worth $24,130. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,000
Previous 20,000
5.0%
Holding current value
$24,130
Previous $148,000
76.35%
% of portfolio
0.02%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding ATNM
# of Institutions
74Shares Held
8.31MCall Options Held
65.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY1.88MShares$2.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$2.06 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA686KShares$871,4140.0% of portfolio
-
State Street Corp Boston, MA603KShares$765,3640.0% of portfolio
-
Acadian Asset Management LLC Boston, MA454KShares$576,1910.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $32M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...